Login

Interim Balance Sheets

In USD, except per-share amounts
Q2 FY2020
As of Oct 31, 2019
Q1 FY2020
As of Jul 31, 2019
Q4 FY2019
As of Apr 30, 2019
Q3 FY2019
As of Jan 31, 2019
Q2 FY2019
As of Oct 31, 2018
Q1 FY2019
As of Jul 31, 2018
Q4 FY2018
As of Apr 30, 2018
Q3 FY2018
As of Jan 31, 2018
Q2 FY2018
As of Oct 31, 2017
Q1 FY2018
As of Jul 31, 2017
Q4 FY2017
As of Apr 30, 2017
Q3 FY2017
As of Jan 31, 2017
Q2 FY2017
As of Oct 31, 2016
Q1 FY2017
As of Jul 31, 2016
Q4 FY2016
As of Apr 30, 2016
Q3 FY2016
As of Jan 31, 2016
Q2 FY2016
As of Oct 31, 2015
Q1 FY2016
As of Jul 31, 2015
Q4 FY2015
As of Apr 30, 2015
Q3 FY2015
As of Jan 31, 2015
ASSETS
Current Assets
Cash
Prepaids
Total Current Assets
Intangible Assets, net (Note 4)
Equipment, net (Note 4)
Intangible Assets, net (Note 5)
Mineral Properties (Note 9)
TOTAL ASSETS
LIABILITIES & STOCKHOLDER'S DEFICIT
LIABILITIES
Current Liabilities
Accounts payable & Accrued interest (Note 5)
Accounts payable & Accrued interest (Note 6)
Due to related party (Note 11)
Convertible loan payable (Note 7)
Interest Accrued
Loans payable (Note 7)
TOTAL CURRENT LIABILITIES
STOCKHOLDER'S DEFICIT
Capital stock authorized: 200,000,000 common shares with a par value $0.0001 Issued and outstanding: 76,758,855 common shares (Note 8) (76,283,855 common shares at April 30, 2019)
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDER'S DEFICIT
TOTAL LIABILITIES & STOCKHOLDER'S DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support